These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

136 related articles for article (PubMed ID: 20609182)

  • 1. Treatment of steroid unresponsive relapse with plasma exchange in aggressive multiple sclerosis.
    Habek M; Barun B; Puretić Z; Brinar VV
    Ther Apher Dial; 2010 Jun; 14(3):298-302. PubMed ID: 20609182
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Dramatic worsening following plasma exchange in severe post-natalizumab withdrawal multiple sclerosis relapse.
    Papeix C; Depaz R; Tourbah A; Stankoff B; Lubetzki C
    Mult Scler; 2011 Dec; 17(12):1520-2. PubMed ID: 21669937
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Severe relapse of multiple sclerosis during plasma exchange treatment.
    Matzke B; Metze C; Winkelmann A; Grossmann A; Hartung HP; Benecke R; Zettl UK
    Mult Scler; 2011 Jun; 17(6):759-62. PubMed ID: 21427132
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Early highly aggressive MS successfully treated by hematopoietic stem cell transplantation.
    Fagius J; Lundgren J; Oberg G
    Mult Scler; 2009 Feb; 15(2):229-37. PubMed ID: 18805841
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Management of worsening multiple sclerosis with mitoxantrone: a review.
    Fox EJ
    Clin Ther; 2006 Apr; 28(4):461-74. PubMed ID: 16750460
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Plasma exchange therapy in steroid-unresponsive relapses in patients with multiple sclerosis.
    Trebst C; Reising A; Kielstein JT; Hafer C; Stangel M
    Blood Purif; 2009; 28(2):108-15. PubMed ID: 19521072
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Home administration of intravenous methylprednisolone for multiple sclerosis relapses: the experience of French multiple sclerosis networks.
    Créange A; Debouverie M; Jaillon-Rivière V; Taithe F; Liban D; Moutereau A; Clavelou P; Defer G
    Mult Scler; 2009 Sep; 15(9):1085-91. PubMed ID: 19556312
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Immunoadsorption therapy for steroid-unresponsive relapses in patients with multiple sclerosis.
    Trebst C; Bronzlik P; Kielstein JT; Schmidt BM; Stangel M
    Blood Purif; 2012; 33(1-3):1-6. PubMed ID: 22086365
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Prospective assessment of the treatment of multiple sclerosis relapses with oral high-dose methylprednisolone: response and tolerability data].
    Pascual AM; Boscá I; Escutia M; Bernat A; Coret F; Casanova B
    Neurologia; 2008 Mar; 23(2):73-7. PubMed ID: 17641984
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Suppressive effect of glucocorticoids on TNF-alpha production is associated with their clinical effect in multiple sclerosis.
    van Winsen LM; Polman CH; Dijkstra CD; Tilders FJ; Uitdehaag BM
    Mult Scler; 2010 Apr; 16(4):500-2. PubMed ID: 20086025
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Plasma immunoadsorption treatment of malignant multiple sclerosis with severe and prolonged relapses].
    de Andrés C; Anaya F; Giménez-Roldán S
    Rev Neurol; 2000 Apr 1-15; 30(7):601-5. PubMed ID: 10859735
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Glucocorticoid treatment reduces T-bet and pSTAT1 expression in mononuclear cells from relapsing remitting multiple sclerosis patients.
    Frisullo G; Nociti V; Iorio R; Katia Patanella A; Bianco A; Caggiula M; Sancricca C; Tonali PA; Mirabella M; Batocchi AP
    Clin Immunol; 2007 Sep; 124(3):284-93. PubMed ID: 17627892
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Plasma exchange in severe acute relapses of multiple sclerosis - Results from a Portuguese cohort.
    Correia I; Ribeiro JJ; Isidoro L; Batista S; Nunes C; Macário C; Borges C; Tomaz J; Sousa L
    Mult Scler Relat Disord; 2018 Jan; 19():148-152. PubMed ID: 29241141
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Predicting beta-interferon failure in relapsing-remitting multiple sclerosis.
    O'Rourke K; Walsh C; Antonelli G; Hutchinson M
    Mult Scler; 2007 Apr; 13(3):336-42. PubMed ID: 17439902
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effect of treatment with methylprednisolone on the serum levels of IL-12, IL-10 and CCL2 chemokine in patients with multiple sclerosis in relapse.
    Rentzos M; Nikolaou C; Rombos A; Evangelopoulos ME; Kararizou E; Koutsis G; Zoga M; Dimitrakopoulos A; Tsoutsou A; Sfangos C
    Clin Neurol Neurosurg; 2008 Dec; 110(10):992-6. PubMed ID: 18657352
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Treatment of acute relapses in neuromyelitis optica: Steroids alone versus steroids plus plasma exchange.
    Abboud H; Petrak A; Mealy M; Sasidharan S; Siddique L; Levy M
    Mult Scler; 2016 Feb; 22(2):185-92. PubMed ID: 25921047
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Multiple sclerosis relapses: a multivariable analysis of residual disability determinants.
    Vercellino M; Romagnolo A; Mattioda A; Masera S; Piacentino C; Merola A; Chiò A; Mutani R; Cavalla P
    Acta Neurol Scand; 2009 Feb; 119(2):126-30. PubMed ID: 18684216
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Post-marketing survey on clinical response to interferon beta in relapsing multiple sclerosis: the Roman experience.
    Pozzilli C; Prosperini L; Sbardella E; De Giglio L; Onesti E; Tomassini V
    Neurol Sci; 2005 Dec; 26 Suppl 4():S174-8. PubMed ID: 16388353
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Tolerability and safety profile of 12- to 28-week treatment with interferon beta-1b 250 and 500 microg QOD in patients with relapsing-remitting multiple sclerosis: a multicenter, randomized, double-blind, parallel-group pilot study.
    Hurwitz BJ; Jeffery D; Arnason B; Bigley K; Coyle P; Goodin D; Kaba S; Kirzinger S; Lynch S; Mandler R; Mikol D; Rammohan K; Sater R; Sriram S; Thrower B; Boateng F; Jakobs P; Wash MB; Bogumil T
    Clin Ther; 2008 Jun; 30(6):1102-12. PubMed ID: 18640466
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effect of intravenous methylprednisolone on the number, size and confluence of plaques in relapsing-remitting multiple sclerosis.
    Zivadinov R; Zorzon M; De Masi R; Nasuelli D; Cazzato G
    J Neurol Sci; 2008 Apr; 267(1-2):28-35. PubMed ID: 17945260
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.